Micah T Prochaska1, Samuel F Hohmann2,3, Matthew Modes4, Vineet M Arora5. 1. Department of Medicine, The University of Chicago, Chicago, Illinois, USA. mprochas@medicine.bsd.uchicago.edu. 2. Vizient, Chicago, Illinois, USA. 3. Department of Health Systems Management, Rush University, Chicago, Illinois, USA. 4. Department of Medicine, University of Washington, Seattle, Washington, USA. 5. Department of Medicine, The University of Chicago, Chicago, Illinois, USA.
Abstract
BACKGROUND: Identifying hospitals that are both early and consistent adopters of high-value care can help shed light on the culture and practices at those institutions that are necessary to promote high-value care nationwide. The use of troponin to diagnose acute myocardial infarction (AMI), and not to test for myoglobin or creatine kinase-MB (CK-MB), is a high-value recommendation of the Choosing Wisely® campaign. OBJECTIVE: To examine the variation in cardiac biomarker testing and the effect of the Choosing Wisely® troponin-only recommendation for the diagnosis of AMI. DESIGN: A retrospective observational study using administrative ordering data from Vizient's Clinical Database/Resource Manager. SETTING: Ninety-one academic medical centers from the fourth quarter of 2013 through the third quarter of 2016. PATIENTS: Hospitalized patients with a principal discharge diagnosis of AMI. INTERVENTION: The Choosing Wisely® recommendation to order troponin-only testing to diagnose AMI was released during the first quarter of 2015. RESULTS: In 19 hospitals, troponin-only testing was consistently ordered to diagnose AMI before the Choosing Wisely® recommendation and throughout the study period. In 34 hospitals, both troponin and myoglobin/CK-MB were ordered to diagnose AMI even after the Choosing Wisely® recommendation. In 26 hospitals with low rates of troponin-only testing before the Choosing Wisely® recommendation, the release of the recommendation was associated with a statistically significant increase in the rate of troponin-only testing to diagnose AMI. CONCLUSIONS: In institutions with low rates of troponin-only testing prior to the Choosing Wisely® recommendation, the recommendation was associated with a significant increase in the rate of troponin-only testing.
BACKGROUND: Identifying hospitals that are both early and consistent adopters of high-value care can help shed light on the culture and practices at those institutions that are necessary to promote high-value care nationwide. The use of troponin to diagnose acute myocardial infarction (AMI), and not to test for myoglobin or creatine kinase-MB (CK-MB), is a high-value recommendation of the Choosing Wisely® campaign. OBJECTIVE: To examine the variation in cardiac biomarker testing and the effect of the Choosing Wisely® troponin-only recommendation for the diagnosis of AMI. DESIGN: A retrospective observational study using administrative ordering data from Vizient's Clinical Database/Resource Manager. SETTING: Ninety-one academic medical centers from the fourth quarter of 2013 through the third quarter of 2016. PATIENTS: Hospitalized patients with a principal discharge diagnosis of AMI. INTERVENTION: The Choosing Wisely® recommendation to order troponin-only testing to diagnose AMI was released during the first quarter of 2015. RESULTS: In 19 hospitals, troponin-only testing was consistently ordered to diagnose AMI before the Choosing Wisely® recommendation and throughout the study period. In 34 hospitals, both troponin and myoglobin/CK-MB were ordered to diagnose AMI even after the Choosing Wisely® recommendation. In 26 hospitals with low rates of troponin-only testing before the Choosing Wisely® recommendation, the release of the recommendation was associated with a statistically significant increase in the rate of troponin-only testing to diagnose AMI. CONCLUSIONS: In institutions with low rates of troponin-only testing prior to the Choosing Wisely® recommendation, the recommendation was associated with a significant increase in the rate of troponin-only testing.
Authors: Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Hugo A Katus; Bertil Lindahl; David A Morrow; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Robert O Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasché; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; José-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michal Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis Journal: Circulation Date: 2012-08-24 Impact factor: 29.690
Authors: Ezra A Amsterdam; Nanette K Wenger; Ralph G Brindis; Donald E Casey; Theodore G Ganiats; David R Holmes; Allan S Jaffe; Hani Jneid; Rosemary F Kelly; Michael C Kontos; Glenn N Levine; Philip R Liebson; Debabrata Mukherjee; Eric D Peterson; Marc S Sabatine; Richard W Smalling; Susan J Zieman Journal: Circulation Date: 2014-09-23 Impact factor: 29.690
Authors: Rachel D Le; Joshua M Kosowsky; Adam B Landman; Ida Bixho; Stacy E F Melanson; Milenko J Tanasijevic Journal: Am J Emerg Med Date: 2014-10-20 Impact factor: 2.469
Authors: John W Pickering; Martin P Than; Louise Cullen; Sally Aldous; Ewoud Ter Avest; Richard Body; Edward W Carlton; Paul Collinson; Anne Marie Dupuy; Ulf Ekelund; Kai M Eggers; Christopher M Florkowski; Yonathan Freund; Peter George; Steve Goodacre; Jaimi H Greenslade; Allan S Jaffe; Sarah J Lord; Arash Mokhtari; Christian Mueller; Andrew Munro; Sebbane Mustapha; William Parsonage; W Frank Peacock; Christopher Pemberton; A Mark Richards; Juan Sanchis; Lukas P Staub; Richard Troughton; Raphael Twerenbold; Karin Wildi; Joanna Young Journal: Ann Intern Med Date: 2017-04-18 Impact factor: 25.391
Authors: Alan Rosenberg; Abiy Agiro; Marc Gottlieb; John Barron; Peter Brady; Ying Liu; Cindy Li; Andrea DeVries Journal: JAMA Intern Med Date: 2015-12 Impact factor: 21.873
Authors: Marc R Larochelle; Amy M Knight; Hardin Pantle; Stefan Riedel; Jeffrey C Trost Journal: J Gen Intern Med Date: 2014-06-28 Impact factor: 5.128
Authors: Elizabeth H Bradley; Leslie A Curry; Shoba Ramanadhan; Laura Rowe; Ingrid M Nembhard; Harlan M Krumholz Journal: Implement Sci Date: 2009-05-08 Impact factor: 7.327
Authors: Emilie P Belley-Cote; André Lamy; P J Devereaux; Peter Kavsak; François Lamontagne; Deborah J Cook; Kevin Kennedy; Jessica Vincent; Yongning Ou; George Tagarakis; Richard P Whitlock Journal: Eur J Cardiothorac Surg Date: 2020-01-01 Impact factor: 4.191
Authors: Andrew J Admon; Ashwin Gupta; Margaret Williams; Thomas S Valley; Michael W Sjoding; Renda Soylemez Wiener; Colin R Cooke Journal: J Hosp Med Date: 2018-04-25 Impact factor: 2.960